OR WAIT null SECS
Editor of Pharmaceutical Technology Europe
April 02, 2024
A revised regulatory variation framework should make lifecycle management more efficient in Europe.
March 21, 2024
More synthetic opioids have been placed under the strictest controls in the United Kingdom.
March 07, 2024
New plans laid out by AstraZeneca will see £650 million ($828 million) be invested into the UK.
March 02, 2024
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
Wider life sciences industries in the UK and Europe are receiving favourable financial support from governing bodies.
February 21, 2024
AstraZeneca has completed its acquisition of Icosavax, gaining the IVX-A12 vaccine candidate that targets RSV and hMPV.